Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Plasma cell 2Lymphoid 1

Conditions

Multiple Myeloma 2Lymphoma 2Sarcoma 1Preleukemia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Osteosarcoma 1Neoplasms, Plasma Cell 1Neoplasms by Histologic Type 1Neoplasms 1Myelodysplastic Syndromes 1Mobility Limitation 1Melanoma 1Lymphoproliferative Disorders 1Lymphoma, B-Cell, Marginal Zone 1Lymphatic Diseases 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphoid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Leukemia, B-Cell 1Leukemia 1Kidney Neoplasms 1Immunoproliferative Disorders 1Immune System Diseases 1Hematologic Diseases 1Head and Neck Neoplasms 1Esophageal Neoplasms 1

Interventions

Dexamethasone 114daratumumab 68Lenalidomide 66Bortezomib 55pomalidomide 44carfilzomib 39Cyclophosphamide 33Specimen Handling 30Calcium Dobesilate 30Biopsy 27Magnetic Resonance Spectroscopy 24belantamab mafodotin 20isatuximab 19fludarabine 17talquetamab 16iberdomide 15Melphalan 15dexamethasone acetate 13dexamethasone 21-phosphate 13auricularum 13fludarabine phosphate 11selinexor 10elotuzumab 10tocilizumab 9X-Rays 8Nivolumab 8Sirolimus 7trametinib 6Whole-Body Irradiation 6Mycophenolic Acid 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Multiple Myeloma × Patient Reported Outcome Measures × 90 days × Clear all
NCT05831787 2026-05-18

COSMIC

ASH Research Collaborative

Completed
201 enrolled 15 charts
Plasma cell

COVID-19, Multiple Myeloma, Neoplasms, Plasma Cell

NCT07558057 2026-04-30

COGNITOX

University of Aarhus

Not yet recruiting
225 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Lymphoma, B-Cell, Marginal Zone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡